Search
Search Results
##search.searchResults.foundPlural##
-
TREATMENT OF ACUTE MYELOID LEUKEMIA WITH 20-30% BONE MARROW BLASTS
2806PDF: 1010HTML: 5521 -
IMMUNOLOGY OF TUBERCULOSIS
5314PDF: 2013HTML: 7322Untitled: 195 -
IMPORTANCE OF CLASSICAL MORPHOLOGY IN THE DIAGNOSIS OF MYELODYSPLASTIC SYNDROME
3310PDF: 2270HTML: 23330Untitled: 203Untitled: 217Untitled: 231 -
Massive pulmonary embolism at the onset of acute promyelocytic leukemia
3512PDF: 891HTML: 1653figure 1: 165Untitled: 189 -
MYELODYSPLASTIC SYNDROMES AND IRON CHELATION THERAPY
3388PDF: 1294HTML: 1905Fig.1: 200Fig. 2: 208 -
Guest Editor: Raffaella Origa IRON TOXICITY AND HEMOPOIETIC CELL TRANSPLANTATION: TIME TO CHANGE THE PARADIGM. IRON TOXICITY AND HEMOPOIETIC CELL TRANSPLANTATION
1917PDF: 1217HTML: 238 -
ALLOGENEIC TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC LEUKEMIA
1372PDF: 758HTML: 942 -
Cytomorphology of Chimeric Antigen Receptor T-Cells (CAR-T)
1212PDF: 514HTML: 224 -
HEMATOPOIETIC STEM CELL TRNSPLANTATION IN THALASSEMIA AND RELATED DISORDERS
1410PDF: 491HTML: 3975 -
FLT3 Mutated Acute Myeloid Leukemia after CD19 CAR-T Cells
955PDF: 1208HTML: 111 -
Coagulopathy in Patients with Low/Intermediate Risk Acute Promyelocytic Leukemia treated with First Line Arsenic Trioxide in Combination with All Trans Retinoic Acid: A Monocentric Experience. Coagulopathy in APL treated with ATRA and Arsenic Trioxide.
1075PDF: 1069HTML: 443 -
CMV MANAGEMENT WITH SPECIFIC IMMUNOGLOBULINS: A MULTICENTRIC RETROSPECTIVE ANALYSIS ON 92 ALLOTRANSPLANTED PATIENTS. Anti-CMV immunoglobulins for CMV treatment
1946PDF: 1166HTML: 268 -
TREATMENT OF ADVANCED SYSTEMIC MASTOCYTOSIS WITH MIDOSTAURIN: PRACTICAL GUIDANCE FOR OPTIMAL THERAPY AND MANAGEMENT Advanced systemic mastocytosis and midostaurin
1247PDF: 1000HTML: 211
1 - 28 of 28 items







